VOR
Vor Biopharma Inc.
$20.31
+0.21 (+1.04%)
At close · Jul 8
Market Cap
$1.10B
Shares
54,185,877
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$695.98M
-495.3%
FY2025
Diluted EPS
-$70.50
-107.4%
FY2025
Operating Cash Flow
-$142.71M
-43.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $312.43M | $321.53M | $93.31M | $94.32M | $64.55M | $47.53M | |
| $61.09M | $50.11M | $27.88M | $31.72M | $28.87M | $21.49M | |
| — | $29.71M | — | — | — | — | |
| $373.51M | $371.64M | $121.19M | $126.04M | $93.42M | $69.02M | |
| -$373.51M | -$371.64M | -$121.19M | -$126.04M | -$93.42M | -$69.02M | |
| $9M | $5.87M | $4.27M | $8.17M | $1.32M | $119K | |
| -$509.57M | -$324.34M | $4.27M | $8.17M | $1.32M | $119K | |
| -$883.08M | -$695.98M | -$116.91M | -$117.86M | -$92.09M | -$68.9M | |
| — | — | — | -$117.86M | -$92.09M | -$70.13M | |
| -$883.81M | -$695.96M | -$116.82M | -$117.17M | -$92.86M | — | |
| USD/shares | — | -$70.50 | -$34.00 | -$35.00 | -$46.60 | — |
| USD/shares | — | -$70.50 | -$34.00 | -$35.00 | -$46.60 | — |
| shares | — | 9.87M | 3.44M | 3.36M | 1.98M | 1.67M |
| shares | — | 9.87M | 3.44M | 3.36M | 1.98M | 1.67M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: $0 in dividends.